Association between PIK3CA mutation status and development of brain metastases in HR+/HER2-metastatic breast cancer

被引：0

作者：

Fitzgerald, D. M. ^{[1
]}

Muzikansky, A. ^{[2
]}

Pinto, C. ^{[2
]}

Henderson, L. ^{[3
]}

Walmsley, C. ^{[3
]}

Allen, R. ^{[4
]}

Ferraro, G. B. ^{[3
]}

Isakoff, S. ^{[5
]}

Moy, B. ^{[3
]}

Oh, K. ^{[2
]}

Shih, H. A. ^{[2
]}

Dias-Santagata, D. ^{[3
]}

Iafrate, A. J. ^{[2
]}

Bardia, A. ^{[6
]}

Brastianos, P. K. ^{[2
]}

Juric, D. ^{[7
]}

机构：

[1] Harvard Med Sch, Termeer Ctr Targeted Therapies, Massachusetts Gen Hosp, Boston, MA 02115 USA

[2] Harvard Med Sch, Ctr Canc, Massachusetts Gen Hosp, Boston, MA 02115 USA

[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA

[4] Massachusetts Gen Hosp, Med Oncol, Boston, MA 02114 USA

[5] Massachusetts Gen Hosp, Hematol & Oncol, Boston, MA 02114 USA

[6] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA

[7] Massachusetts Gen Hosp, Termeer Ctr Targeted Therapies, Boston, MA 02114 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

318P

引用

页数：1